Altogether, the siRNA results and results obtained with two small-molecule inhibitors tested on HSCs and LX-2 cells confirm the causal role of EP300 in liver fibrosis, which is in agreement with the results from our weighted, directional data-driven disease network. This evidence concerns the gene EP300 and Hepatic fibrosis.